CERO THERAPEUTICS HOLDINGS, INC. (CERO) Debt Components
- 2026-06-30: Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m); Long-term DebtUSD (m); Line of Credit Facility, Maximum Month-end Outstanding AmountUSD (m).
- 2026-06-30: Convertible Notes Payable, CurrentUSD $746.65K; Convertible Notes PayableUSD (m); Long-term DebtUSD (m); Line of Credit Facility, Maximum Month-end Outstanding AmountUSD (m).
- 2026-06-23: Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD $663.60K; Long-term DebtUSD (m); Line of Credit Facility, Maximum Month-end Outstanding AmountUSD (m).
- 2026-03-31: Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m); Long-term DebtUSD (m); Line of Credit Facility, Maximum Month-end Outstanding AmountUSD (m).
CERO THERAPEUTICS HOLDINGS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Convertible Notes Payable USD | Long-term Debt USD | Line of Credit Facility, Maximum Month-end Outstanding Amount USD | Line of Credit Facility, Periodic Payment, Principal USD | Long-term Debt, Gross USD | Debt Instrument, Face Amount USD | Debt Instrument, Unamortized Discount, Current USD | Debt Instrument Issued Principal USD | Notes Payable, Current USD | Notes Payable, Related Parties, Current USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | (m) | 6 month · $1.44M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-06-30 | $746.65K | (m) | (m) | (m) | (m) | $746.65K | $4.58M | $3.83M | (m) | (m) | (m) |
| 2026-06-23 | (m) | $663.60K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | (m) | (m) | 3 month · $164.87K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | $136.76K | (m) | (m) | $136.76K | $1.88M | $1.74M | (m) | (m) | (m) |
| 2026-03-06 | (m) | (m) | (m) | $1.00M | (m) | (m) | (m) | (m) | $937.50K | (m) | (m) |
| 2026-02-09 | (m) | $750.00K | (m) | $1.00M | (m) | (m) | (m) | (m) | $937.50K | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.40M | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.18M | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $650.00K |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $650.00K | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $650.00K |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |